In a group of renal transplant recipients with new-onset diabetes mellitus after a transplant in whom glycemia was not controlled adequately by oral hypoglycemic agents , the addition of sitagliptin helped to achieve glycemic control similar to insulin glargine but with a marginal weight advantage .